Literature DB >> 3927252

Aminophylline reduces hypoxic ventilatory depression: possible role of adenosine.

R A Darnall.   

Abstract

Newborn infants and animals typically exhibit a paradoxical ventilatory response to hypoxia. The depressive phase of the response has not been adequately explained. It has been suggested that hypoxia may cause the release of inhibitory neuromodulators which depress ventilation. We have postulated that the nucleoside, adenosine, may be involved because 1) it is rapidly released during hypoxia, 2) it depresses ventilation, and 3) theophylline, a competitive inhibitor, has successfully been used to treat apnea of prematurity. Herein we describe the effects of aminophylline on ventilation during hypoxia in the spontaneously breathing newborn piglet administered both rapidly after ventilatory depression has occurred (bolus) and before the onset of hypoxia (pretreatment). Ten percent oxygen breathing produced a typical biphasic ventilatory response. The decrease in minute ventilation was caused by a decrease in both tidal volume and respiratory frequency. The bolus administration of aminophylline reversed the depression in minute ventilation (p less than 0.001) by increasing tidal volume (p less than 0.002). Pretreatment with aminophylline decreased the amount of ventilatory depression (p less than 0.05) by preventing a decrease in respiratory frequency. We conclude that aminophylline, an adenosine antagonist, reduces the decrease in ventilation which occurs during hypoxia in the newborn. We speculate that adenosine may play a role in hypoxic ventilatory depression and respiratory control in the newborn.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3927252     DOI: 10.1203/00006450-198507000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  Arousal from sleep in response to intermittent hypoxia in rat pups is modulated by medullary raphe GABAergic mechanisms.

Authors:  Robert A Darnall; Robert W Schneider; Christine M Tobia; Benjamin M Zemel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

2.  Postnatal development of the pattern of respiratory and cardiovascular response to systemic hypoxia in the piglet: the roles of adenosine.

Authors:  B Elnazir; J M Marshall; P Kumar
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

Review 3.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 4.  The carotid body and arousal in the fetus and neonate.

Authors:  Robert A Darnall
Journal:  Respir Physiol Neurobiol       Date:  2012-06-08       Impact factor: 1.931

5.  Adenosine receptors mediate the hypoxic ventilatory response but not the hypoxic metabolic response in the naked mole rat during acute hypoxia.

Authors:  Matthew E Pamenter; Yvonne A Dzal; William K Milsom
Journal:  Proc Biol Sci       Date:  2015-02-07       Impact factor: 5.349

6.  The role of adenosine in the respiratory and cardiovascular response to systemic hypoxia in the rat.

Authors:  M Neylon; J M Marshall
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

7.  Effect of aminophylline on cerebral haemodynamics and oxidative metabolism in premature infants.

Authors:  H U Bucher; M Wolf; M Keel; K von Siebenthal; G Duc
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

8.  Aminophylline and increased activity of peripheral chemoreceptors in newborn infants.

Authors:  L Cattarossi; S Rubini; F Macagno
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

Review 9.  Oral theophylline for chronic obstructive pulmonary disease.

Authors:  F S Ram; P W Jones; A A Castro; J A De Brito; A N Atallah; Y Lacasse; R Mazzini; R Goldstein; S Cendon
Journal:  Cochrane Database Syst Rev       Date:  2002

10.  Effects of theophylline on ventilatory response to hypoxic challenge.

Authors:  J Milerad
Journal:  Arch Dis Child       Date:  1987-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.